Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Tumor-associated macrophages promote invasion while retaining Fc-dependent anti-tumor function.

Grugan KD, McCabe FL, Kinder M, Greenplate AR, Harman BC, Ekert JE, van Rooijen N, Anderson GM, Nemeth JA, Strohl WR, Jordan RE, Brezski RJ.

J Immunol. 2012 Dec 1;189(11):5457-66. doi: 10.4049/jimmunol.1201889. Epub 2012 Oct 26.

2.

Circulating human interleukin-8 as an indicator of cancer progression in a nude rat orthotopic human non-small cell lung carcinoma model.

Millar HJ, Nemeth JA, McCabe FL, Pikounis B, Wickstrom E.

Cancer Epidemiol Biomarkers Prev. 2008 Aug;17(8):2180-7. doi: 10.1158/1055-9965.EPI-07-2915.

3.

CNTO 95, a fully human anti alphav integrin antibody, inhibits cell signaling, migration, invasion, and spontaneous metastasis of human breast cancer cells.

Chen Q, Manning CD, Millar H, McCabe FL, Ferrante C, Sharp C, Shahied-Arruda L, Doshi P, Nakada MT, Anderson GM.

Clin Exp Metastasis. 2008;25(2):139-48. Epub 2007 Dec 5.

PMID:
18064530
4.

Alphav integrin-targeted immunoconjugates regress established human tumors in xenograft models.

Chen Q, Millar HJ, McCabe FL, Manning CD, Steeves R, Lai K, Kellogg B, Lutz RJ, Trikha M, Nakada MT, Anderson GM.

Clin Cancer Res. 2007 Jun 15;13(12):3689-95.

5.

Regulation of vascular endothelial growth factor expression by EMMPRIN via the PI3K-Akt signaling pathway.

Tang Y, Nakada MT, Rafferty P, Laraio J, McCabe FL, Millar H, Cunningham M, Snyder LA, Bugelski P, Yan L.

Mol Cancer Res. 2006 Jun;4(6):371-7.

6.

High-dose recombinant interleukin-18 induces an effective Th1 immune response to murine MOPC-315 plasmacytoma.

Jonak ZL, Trulli S, Maier C, McCabe FL, Kirkpatrick R, Johanson K, Ho YS, Elefante L, Chen YJ, Herzyk D, Lotze MT, Johnson RK.

J Immunother. 2002 Mar-Apr;25 Suppl 1:S20-7.

PMID:
12048347
7.

Limonoids showing selective toxicity to DNA repair-deficient yeast and other constituents of Trichilia emetica.

Gunatilaka AA, Bolzani Vda S, Dagne E, Hofmann GA, Johnson RK, McCabe FL, Mattern MR, Kingston DG.

J Nat Prod. 1998 Feb;61(2):179-84.

PMID:
9514005
8.

Bioactive and other sesquiterpenes from Chiloscyphus rivularis.

Wu C, Gunatilaka AA, McCabe FL, Johnson RK, Spjut RW, Kingston DG.

J Nat Prod. 1997 Dec;60(12):1281-6.

PMID:
9463110
9.
10.

In vitro and in vivo effects of clinically important camptothecin analogues on multidrug-resistant cells.

Mattern MR, Hofmann GA, Polsky RM, Funk LR, McCabe FL, Johnson RK.

Oncol Res. 1993;5(12):467-74.

PMID:
8086668
11.

Pharmacokinetics and pharmacodynamics of topotecan in patients with advanced cancer.

Grochow LB, Rowinsky EK, Johnson R, Ludeman S, Kaufmann SH, McCabe FL, Smith BR, Hurowitz L, DeLisa A, Donehower RC, et al.

Drug Metab Dispos. 1992 Sep-Oct;20(5):706-13.

PMID:
1358575
12.

Camptothecin hyper-resistant P388 cells: drug-dependent reduction in topoisomerase I content.

Woessner RD, Eng WK, Hofmann GA, Rieman DJ, McCabe FL, Hertzberg RP, Mattern MR, Tan KB, Johnson RK.

Oncol Res. 1992;4(11-12):481-8.

PMID:
1338578
13.

Synergistic cell killing by ionizing radiation and topoisomerase I inhibitor topotecan (SK&F 104864).

Mattern MR, Hofmann GA, McCabe FL, Johnson RK.

Cancer Res. 1991 Nov 1;51(21):5813-6.

14.

In vivo development and in vitro characterization of a subclone of murine P388 leukemia resistant to bis(diphenylphosphine)ethane.

Hoke GD, McCabe FL, Faucette LF, Bartus JO, Sung CM, Jensen BD, Heys JR, Rush GF, Alberts DW, Johnson RK, et al.

Mol Pharmacol. 1991 Jan;39(1):90-7.

PMID:
1898982
15.

Synthesis of water-soluble (aminoalkyl)camptothecin analogues: inhibition of topoisomerase I and antitumor activity.

Kingsbury WD, Boehm JC, Jakas DR, Holden KG, Hecht SM, Gallagher G, Caranfa MJ, McCabe FL, Faucette LF, Johnson RK, et al.

J Med Chem. 1991 Jan;34(1):98-107.

PMID:
1846923
16.

Development of a stable camptothecin-resistant subline of P388 leukemia with reduced topoisomerase I content.

Eng WK, McCabe FL, Tan KB, Mattern MR, Hofmann GA, Woessner RD, Hertzberg RP, Johnson RK.

Mol Pharmacol. 1990 Oct;38(4):471-80.

PMID:
2172765
17.

Nonproductive rearrangement of DNA topoisomerase I and II genes: correlation with resistance to topoisomerase inhibitors.

Tan KB, Mattern MR, Eng WK, McCabe FL, Johnson RK.

J Natl Cancer Inst. 1989 Nov 15;81(22):1732-5.

PMID:
2553992
18.

Synthesis, tubulin binding, antineoplastic evaluation, and structure-activity relationship of oncodazole analogues.

Kruse LI, Ladd DL, Harrsch PB, McCabe FL, Mong SM, Faucette L, Johnson R.

J Med Chem. 1989 Feb;32(2):409-17.

PMID:
2913301
19.

A murine model to evaluate the ability of in vitro clonogenic assays to predict the response to tumors in vivo.

Mirabelli CK, Sung CM, McCabe FL, Faucette LF, Crooke ST, Johnson RK.

Cancer Res. 1988 Oct 1;48(19):5447-54.

20.

Biological characterization and oncogene expression in human colorectal carcinoma cell lines.

Trainer DL, Kline T, McCabe FL, Faucette LF, Feild J, Chaikin M, Anzano M, Rieman D, Hoffstein S, Li DJ, et al.

Int J Cancer. 1988 Feb 15;41(2):287-96.

PMID:
3338874
21.

Tumorigenicity of the cyc- variant of the S49 murine lymphoma deficient in the Gs-alpha subunit of adenylate cyclase.

Stadel JM, Johnson RK, Mirabelli CK, Powers DA, Sung CM, Faucette LF, McCabe FL, Crooke ST.

Cancer Res. 1988 Feb 1;48(3):641-4.

22.

Purification of topoisomerase II from amsacrine-resistant P388 leukemia cells. Evidence for two forms of the enzyme.

Drake FH, Zimmerman JP, McCabe FL, Bartus HF, Per SR, Sullivan DM, Ross WE, Mattern MR, Johnson RK, Crooke ST, et al.

J Biol Chem. 1987 Dec 5;262(34):16739-47.

23.

Antitumor activity of bis(diphenylphosphino)alkanes, their gold(I) coordination complexes, and related compounds.

Mirabelli CK, Hill DT, Faucette LF, McCabe FL, Girard GR, Bryan DB, Sutton BM, Bartus JO, Crooke ST, Johnson RK.

J Med Chem. 1987 Dec;30(12):2181-90.

PMID:
3681888
24.

In vivo antitumor activity and in vitro cytotoxic properties of bis[1,2-bis(diphenylphosphino)ethane]gold(I) chloride.

Berners-Price SJ, Mirabelli CK, Johnson RK, Mattern MR, McCabe FL, Faucette LF, Sung CM, Mong SM, Sadler PJ, Crooke ST.

Cancer Res. 1986 Nov;46(11):5486-93.

25.

Modulation of the antitumor and biochemical properties of bis(diphenylphosphine)ethane with metals.

Snyder RM, Mirabelli CK, Johnson RK, Sung CM, Faucette LF, McCabe FL, Zimmerman JP, Whitman M, Hempel JC, Crooke ST.

Cancer Res. 1986 Oct;46(10):5054-60.

Supplemental Content

Loading ...
Support Center